Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Avricore Health Inc. is a Canadian health technology company focused on enabling pharmacy-based point-of-care testing (POCT) and health data integration. The company operates at the intersection of healthcare services, diagnostics, and digital health infrastructure, providing tools that allow pharmacies to deliver rapid clinical tests and securely transmit results to patients and healthcare providers. Its business model is centered on supporting preventative care, chronic disease screening, and improved access to diagnostic services outside traditional clinical settings.
The company’s core offering is the HealthTab platform, which integrates diagnostic testing devices with secure data reporting and clinical workflows. Avricore Health was incorporated in 2016 and has evolved from a general health data company into a specialized provider of pharmacy-centric diagnostic solutions. Its strategic positioning emphasizes scalability through large pharmacy networks and alignment with public and private healthcare stakeholders in Canada.
Business Operations
Avricore Health generates revenue primarily through the deployment of its HealthTab platform, which includes hardware integration, software licensing, and per-test or service-based fees associated with diagnostic screenings conducted in pharmacies. The company focuses on enabling tests such as cardiovascular risk assessments, diabetes-related screening, and other chronic disease markers, with an emphasis on rapid results and standardized reporting.
Operations are primarily domestic, with activities concentrated in Canada. Avricore controls the HealthTab Inc. subsidiary, which houses the core technology and commercial relationships. The company collaborates with pharmacy operators, diagnostic equipment manufacturers, and healthcare data stakeholders to deliver its services, with partnerships structured to expand test availability while maintaining regulatory compliance and data security standards.
Strategic Position & Investments
Avricore Health’s strategic direction is centered on expanding the adoption of pharmacy-based diagnostics as a complement to traditional healthcare delivery. Growth initiatives have focused on increasing pharmacy penetration, broadening the menu of supported diagnostic tests, and enhancing data interoperability with healthcare systems. The company has emphasized organic growth through platform expansion rather than large-scale acquisitions.
The firm’s investments are largely directed toward technology development, regulatory alignment, and commercial scaling of HealthTab. Emerging areas of focus include preventative health screening and chronic disease management, leveraging pharmacies as accessible community healthcare hubs. Public disclosures do not indicate material ownership stakes in unrelated portfolio companies, and no major acquisitions have been conclusively verified in available public filings.
Geographic Footprint
Avricore Health’s operations are primarily concentrated in Canada, where it partners with national and regional pharmacy networks. The company is headquartered in Canada, and its commercial footprint reflects the regulatory and reimbursement frameworks of the Canadian healthcare system.
While the company has indicated interest in broader market opportunities, verified public disclosures show no material operational presence outside North America as of the most recent reporting periods. International expansion remains limited or data inconclusive based on available public sources.
Leadership & Governance
Avricore Health is led by an executive team with experience in healthcare services, pharmacy operations, and health technology commercialization. The leadership philosophy emphasizes collaboration with pharmacy partners, data-driven healthcare delivery, and expanding patient access to diagnostics through trusted retail healthcare channels.
Key executives include:
- Hector Bremner – President & Chief Executive Officer
- Arden Brown – Chief Financial Officer
- Shawn O’Neill – Chair of the Board
Public filings and disclosures indicate standard governance practices for a Canadian publicly listed company, with oversight provided by an independent board of directors.